Astera Labs Announces Financial Results for the Third Quarter of Fiscal Year 2024
Astera Labs (NASDAQ: ALAB) reported strong Q3 FY2024 financial results with record quarterly revenue of $113.1 million, up 47% QoQ and 206% YoY. The company achieved a GAAP gross margin of 77.7% but reported a GAAP operating loss of $8.9 million. Non-GAAP results showed operating income of $36.6 million and net income of $40.3 million. For Q4 FY2024, Astera Labs forecasts revenue between $126-130 million with non-GAAP diluted EPS of $0.25-0.26. The company introduced new Scorpio Smart Fabric Switches for AI infrastructure and joined the UALink Consortium as a promoting board member.
Astera Labs (NASDAQ: ALAB) ha riportato forti risultati finanziari per il terzo trimestre dell'anno fiscale 2024, con un fatturato trimestrale record di 113,1 milioni di dollari, in crescita del 47% rispetto al trimestre precedente e del 206% anno su anno. L'azienda ha raggiunto un margine lordo GAAP del 77,7%, ma ha registrato una perdita operativa GAAP di 8,9 milioni di dollari. I risultati non GAAP hanno mostrato un reddito operativo di 36,6 milioni di dollari e un reddito netto di 40,3 milioni di dollari. Per il quarto trimestre dell'anno fiscale 2024, Astera Labs prevede un fatturato compreso tra 126 e 130 milioni di dollari, con un utile per azione diluito non GAAP di 0,25-0,26 dollari. L'azienda ha presentato nuovi Scorpio Smart Fabric Switches per l'infrastruttura AI e si è unita al Consorzio UALink in qualità di membro del consiglio promotore.
Astera Labs (NASDAQ: ALAB) reportó sólidos resultados financieros para el tercer trimestre del año fiscal 2024, con ingresos trimestrales récord de 113,1 millones de dólares, un aumento del 47% en comparación con el trimestre anterior y del 206% interanual. La compañía logró un margen bruto GAAP del 77,7%, pero reportó una pérdida operativa GAAP de 8,9 millones de dólares. Los resultados no GAAP mostraron un ingreso operativo de 36,6 millones de dólares y un ingreso neto de 40,3 millones de dólares. Para el cuarto trimestre del año fiscal 2024, Astera Labs pronostica ingresos entre 126 y 130 millones de dólares, con una utilidad por acción diluida no GAAP de 0,25-0,26 dólares. La empresa presentó nuevos Scorpio Smart Fabric Switches para infraestructura de IA y se unió al Consorcio UALink como miembro del consejo promotor.
아스테라 랩스 (NASDAQ: ALAB)는 2024 회계연도 3분기 재무 결과를 발표하며 사상 최대 분기 수익 1억 1,310만 달러를 기록했습니다. 이는 전 분기 대비 47% 증가했으며, 전년 대비 206% 증가한 수치입니다. 회사는 GAAP 총 마진 77.7%를 달성했지만, GAAP 운영 손실 890만 달러를 보고했습니다. 비 GAAP 결과는 운영 수익 3,660만 달러와 순이익 4,030만 달러를 보였습니다. 2024 회계연도 4분기 동안 아스테라 랩스는 수익을 1억 2,600만 달러에서 1억 3,000만 달러 사이로 예상하며, 비 GAAP 희석 EPS는 0.25-0.26 달러입니다. 이 회사는 AI 인프라를 위한 새로운 스콜피오 스마트 패브릭 스위치를 출시하고, UALink 컨소시엄에 프로모팅 이사로 참여했습니다.
Astera Labs (NASDAQ: ALAB) a annoncé de solides résultats financiers pour le troisième trimestre de l'exercice 2024, avec un chiffre d'affaires trimestriel record de 113,1 millions de dollars, en hausse de 47 % par rapport au trimestre précédent et de 206 % par rapport à l'année précédente. L'entreprise a atteint une marge brute GAAP de 77,7 %, mais a enregistré une perte d'exploitation GAAP de 8,9 millions de dollars. Les résultats non GAAP ont montré un revenu d'exploitation de 36,6 millions de dollars et un revenu net de 40,3 millions de dollars. Pour le quatrième trimestre de l'exercice 2024, Astera Labs prévoit un chiffre d'affaires compris entre 126 et 130 millions de dollars, avec un BPA dilué non GAAP de 0,25-0,26 dollar. L'entreprise a lancé de nouveaux commutateurs de tissu intelligent Scorpio pour l'infrastructure IA et a rejoint le Consortium UALink en tant que membre du conseil promoteur.
Astera Labs (NASDAQ: ALAB) hat starke Finanzzahlen für das dritte Quartal des Geschäftsjahres 2024 gemeldet, mit einem Quartalsumsatzrekord von 113,1 Millionen Dollar, was einem Anstieg von 47% im Vergleich zum vorherigen Quartal und 206% im Jahresvergleich entspricht. Das Unternehmen erreichte eine GAAP-Bruttomarge von 77,7%, berichtete jedoch von einem GAAP-Betriebsverlust von 8,9 Millionen Dollar. Die Non-GAAP-Ergebnisse zeigten ein Betriebsergebnis von 36,6 Millionen Dollar und einen Nettogewinn von 40,3 Millionen Dollar. Für das vierte Quartal 2024 rechnet Astera Labs mit einem Umsatz zwischen 126 und 130 Millionen Dollar bei einem Non-GAAP-dilluten EPS von 0,25-0,26 Dollar. Das Unternehmen führte neue Scorpio Smart Fabric Switches für die KI-Infrastruktur ein und trat dem UALink-Konsortium als förderndes Vorstandsmitglied bei.
- Record quarterly revenue of $113.1 million, growing 206% YoY
- Strong non-GAAP gross margin of 77.8%
- Non-GAAP operating income of $36.6 million
- Positive Q4 guidance with projected revenue growth to $126-130 million
- Non-GAAP net income of $40.3 million
- GAAP operating loss of $8.9 million
- GAAP net loss of $7.6 million
- Negative GAAP operating margin of -7.9%
Insights
Astera Labs delivered exceptional Q3 results with
The company's Q4 guidance projects continued momentum with revenue expected between
Key metrics to watch include the
The launch of Scorpio Smart Fabric Switches represents a significant strategic expansion in Astera's AI infrastructure portfolio. These purpose-built switches, especially the P-Series for PCIe Gen 6 connectivity and X-Series for GPU clustering, address critical bottlenecks in AI compute infrastructure.
Their involvement in the UALink Consortium as a board member positions them at the forefront of developing next-generation AI accelerator connectivity standards. The successful demonstrations at OCP Global Summit, particularly the first live end-to-end PCIe Gen 6 system, validate their technical leadership in high-speed connectivity solutions for AI workloads.
-
Record quarterly revenue of
, up$113.1 million 47% QoQ and up206% YoY - Expanding market opportunities with new Scorpio Fabric Switches, driving higher dollar content in AI platforms
“Astera Labs delivered strong Q3 results, setting our fifth consecutive quarterly revenue record and grew
Third Quarter of Fiscal 2024 Financial Highlights
GAAP Financial Results:
-
Revenue of
, up$113.1 million 47% sequentially and up206% year-over-year -
GAAP gross margin of
77.7% -
GAAP operating loss of
$8.9 million -
GAAP operating margin of (
7.9% ) -
GAAP net loss of
$7.6 million -
GAAP diluted net loss per share of
$0.05
Non-GAAP Financial Results (excluding the impact of stock-based compensation expense and the income tax effects of non-GAAP adjustments):
-
Non-GAAP gross margin of
77.8% -
Non-GAAP operating income of
$36.6 million -
Non-GAAP operating margin of
32.4% -
Non-GAAP net income of
$40.3 million -
Non-GAAP diluted earnings per share of
$0.23
Third Quarter of Fiscal 2024 and Recent Business Highlights
- Introduced new portfolio of Scorpio Smart Fabric Switches purpose-built for AI infrastructure at cloud-scale. The Scorpio Smart Fabric Switch family features two application-specific product lines with a multi-generational roadmap, including the P-Series for GPU-to-CPU/NIC/SSD PCIe Gen 6 connectivity and the X-Series for platform-specific, back-end GPU clustering. Scorpio is currently shipping in pre-production quantities.
- Joined the Ultra Accelerator Link (UALink) Consortium as a promoting member on the Board of Directors. UALink technology will be used to enable efficient high-speed scale-up connectivity between AI accelerators within large and growing cluster sizes for AI workloads. Astera Labs is well positioned to quickly contribute to this new and compelling industry initiative to develop and advance UALink technology.
- Demonstrated current and next-generation product families in collaboration with over a dozen customers and partners at the 2024 OCP Global Summit, including the industry’s first live end-to-end PCIe Gen 6 system leveraging the Scorpio P-Series Fabric Switch and Aries 6 Smart DSP Retimer. Showed live demonstrations of CXL Memory Controllers seamlessly operating with next-generation data center server CPUs. Showcased Aries Smart Cable Modules for both Active Electrical Cable and Active Optical Cable applications to extend reach in multi-rack GPU clustering use-cases, and Taurus Smart Cable Modules to enable high-speed connectivity over Ethernet for front and back-end networking.
- Won the Future of Memory and Storage (FMS) 2024 Most Innovative Technology Award for the ‘AI Inferencing with CXL solution’ category alongside ecosystem partners. The joint demonstration showed AI inferencing benefit gains by using CXL-attached memory. Astera Labs is now a two-time winner at FMS having won the award at FMS 2023 by demonstrating high-performance OLTP (Online Transaction Processing) with CXL-attached memory.
Fourth Quarter of Fiscal 2024 Financial Outlook
Based on current business trends and conditions, Astera Labs estimates the following:
GAAP Financial Outlook:
-
Revenue within a range of
to$126 million $130 million -
GAAP gross margin of approximately
75% -
GAAP operating expenses within a range of approximately
to$101 million $102 million -
GAAP taxes in a range of
to$3 million tax benefit$5 million -
GAAP diluted earnings per share within a range of approximately
to$0.04 on weighted-average diluted shares outstanding of approximately 179 million$0.06
Non-GAAP Financial Outlook (excluding the impact of approximately
-
Non-GAAP gross margin of approximately
75% -
Non-GAAP operating expenses within a range of approximately
to$54 million $55 million -
Non-GAAP tax rate of approximately
10% -
Non-GAAP diluted earnings per share within a range of approximately
to$0.25 on non-GAAP weighted-average diluted shares outstanding of approximately 179 million$0.26
Earnings Webcast and Conference Call
Astera Labs will host a conference call to review its financial results for the third quarter of fiscal 2024 and to discuss our financial outlook today at 1:30 p.m. Pacific Time. Interested parties may join the conference call by dialing 1-800-715-9871 and using conference ID 5908687. The call will also be webcast and can be accessed at the Astera Labs website at https://ir.asteralabs.com/. The webcast will be recorded and available for replay on the company’s website for the next six months.
Discussion of Non-GAAP Financial Measures
We use certain non-GAAP financial measures to supplement the performance measures in our consolidated financial statements, which are presented in accordance with GAAP. A reconciliation of these non-GAAP measures to the closest GAAP measure can be found later in this release. These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income (loss), non-GAAP diluted earnings (loss) per share, and non-GAAP weighted-average share count. We use these non-GAAP financial measures for financial and operational decision-making and as a means to assist us in evaluating period-to-period comparisons. By excluding certain items that may not be indicative of our recurring core operating results, we believe that, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income (loss), non-GAAP pro forma diluted earnings (loss) per share, and non-GAAP pro forma weighted-average share count provide meaningful supplemental information regarding our performance. Accordingly, we believe these non-GAAP financial measures are useful to investors and others because they allow for additional information with respect to financial measures used by management in its financial and operational decision-making and they may be used by our institutional investors and the analyst community to help them analyze the health of our business. However, there are a number of limitations related to the use of non-GAAP financial measures, and these non-GAAP measures should be considered in addition to, not as a substitute for or in isolation from, our financial results prepared in accordance with GAAP. Other companies, including companies in our industry, may calculate these non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures. No reconciliation is provided with respect to the forward-looking non-GAAP financial measures included in our non-GAAP financial outlook, as the GAAP measures are not accessible on a forward-looking basis. As a result, we cannot reliably predict all necessary components or their impact to reconcile such financial measures without unreasonable effort. The events necessitating a non-GAAP adjustment are inherently unpredictable and may have a significant impact on our future GAAP financial results.
We adjust the following items from one or more of our non-GAAP financial measures:
Stock-based compensation expense
We exclude stock-based compensation expense, which is a non-cash expense, from certain of our non-GAAP financial measures because we believe that excluding this item provides meaningful supplemental information regarding operational performance. In particular, companies calculate non-cash stock-based compensation expense using a variety of valuation methodologies and subjective assumptions. Moreover, stock-based compensation expense is a non-cash charge that can vary significantly from period to period for reasons that are unrelated to our core operating performance, and therefore excluding this item provides investors and other users of our financial information with information that allows meaningful comparisons of our business performance across periods.
Employer payroll taxes related to stock-based compensation resulting from our IPO
We exclude employer payroll taxes related to the time-based vesting and net settlement of restricted stock units in connection with our initial public offering (the “IPO”), because this does not correlate to the operation of our business. We believe that excluding this item provides meaningful supplemental information regarding operational performance given the amount of employer payroll tax-related items on employee stock transactions was immaterial prior to our IPO.
Income tax effect
This represents the impact of the non-GAAP adjustments on an after-tax basis and one-off discrete tax adjustments that are unrelated to our core operating performance in connection with the presentation of non-GAAP net income (loss) and non-GAAP net income (loss) per diluted share. This approach is designed to enhance investors’ ability to understand the impact of our non-GAAP tax expense on its current operations, provide improved modeling accuracy, and substantially reduce fluctuations caused by GAAP to non-GAAP adjustments.
Non-GAAP pro forma weighted-average shares to compute non-GAAP pro forma net income (loss) per share
We present non-GAAP pro forma weighted-average shares, assuming our redeemable convertible preferred stock is converted from the beginning of each respective periods presented, to provide meaningful supplemental information regarding EPS trend on a consistent basis. All of our outstanding redeemable preferred stock converted into the equivalent number of shares of common stock in connection with our IPO.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements based on Astera Labs' current expectations. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Astera Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Astera Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. These forward-looking statements include but are not limited to, statements regarding our future operating results, financial position and guidance, our business strategy and plans, our objectives for future operations, our development or delivery of new or enhanced products and anticipated results of those products for our customers, including the anticipated market opportunity and success of the Scorpio Smart Fabric Switch family of products and our AI platform dollar content opportunity, our competitive positioning, technological capabilities and plans, and macroeconomic trends in cloud and AI infrastructure. A variety of risks and factors that are beyond our control could cause actual results to differ materially from those in the forward-looking statements including, without limitation: the competitive and cyclical nature of the semiconductor industry; the concentration of our customer base; the changes in demand for AI; the challenging macroeconomic environment; risks that demand and the supply chain may be adversely affected, including by military conflict (such as between
About Astera Labs
Our PCIe, CXL and Ethernet semiconductor-based connectivity solutions are purpose-built to unleash the full potential of accelerated computing at cloud-scale. Inspired by trusted partnerships with hyperscalers and the data center ecosystem, we are an innovation leader of products that are customizable, interoperable, and reliable. Discover how we are transforming AI and modern data-driven applications at www.asteralabs.com.
ASTERA LABS, INC. |
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (In thousands) |
||||||||
|
|
September 30,
|
|
December 31,
|
||||
Assets |
|
|
|
|
||||
Current assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
126,117 |
|
|
$ |
45,098 |
|
Marketable securities |
|
|
760,684 |
|
|
|
104,215 |
|
Accounts receivable, net |
|
|
25,386 |
|
|
|
8,335 |
|
Inventory |
|
|
24,415 |
|
|
|
24,095 |
|
Prepaid expenses and other current assets |
|
|
8,987 |
|
|
|
4,064 |
|
Total current assets |
|
|
945,589 |
|
|
|
185,807 |
|
Property and equipment, net |
|
|
35,137 |
|
|
|
4,712 |
|
Other assets |
|
|
2,339 |
|
|
|
5,773 |
|
Total assets |
|
$ |
983,065 |
|
|
$ |
196,292 |
|
|
|
|
|
|
||||
Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) |
||||||||
Current liabilities |
|
|
|
|
||||
Accounts payable |
|
$ |
18,551 |
|
|
$ |
6,337 |
|
Accrued expenses and other current liabilities |
|
|
69,489 |
|
|
|
28,742 |
|
Total current liabilities |
|
|
88,040 |
|
|
|
35,079 |
|
Other liabilities |
|
|
5,413 |
|
|
|
3,787 |
|
Total liabilities |
|
|
93,453 |
|
|
|
38,866 |
|
Commitments and contingencies |
|
|
|
|
||||
Redeemable convertible preferred stock |
|
|
— |
|
|
|
255,127 |
|
Stockholders’ equity (deficit) |
|
|
|
|
||||
Common stock |
|
|
16 |
|
|
|
4 |
|
Additional paid-in capital |
|
|
1,118,675 |
|
|
|
27,411 |
|
Accumulated other comprehensive income |
|
|
4,430 |
|
|
|
259 |
|
Accumulated deficit |
|
|
(233,509 |
) |
|
|
(125,375 |
) |
Total stockholders’ equity (deficit) |
|
|
889,612 |
|
|
|
(97,701 |
) |
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) |
|
$ |
983,065 |
|
|
$ |
196,292 |
|
ASTERA LABS, INC. |
||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (In thousands, except per share amounts) |
||||||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
September 30,
|
|
June 30,
|
|
September 30,
|
|
September 30,
|
|
September 30,
|
||||||||||
Revenue |
|
$ |
113,086 |
|
|
$ |
76,850 |
|
|
$ |
36,928 |
|
|
$ |
255,194 |
|
|
$ |
65,280 |
|
Cost of revenue |
|
|
25,209 |
|
|
|
16,996 |
|
|
|
8,823 |
|
|
|
56,943 |
|
|
|
24,478 |
|
Gross profit |
|
|
87,877 |
|
|
|
59,854 |
|
|
|
28,105 |
|
|
|
198,251 |
|
|
|
40,802 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating expenses |
|
|
|
|
|
|
|
|
|
|
||||||||||
Research and development |
|
|
50,659 |
|
|
|
40,089 |
|
|
|
20,626 |
|
|
|
144,306 |
|
|
|
53,753 |
|
Sales and marketing |
|
|
23,248 |
|
|
|
22,076 |
|
|
|
5,507 |
|
|
|
100,834 |
|
|
|
14,997 |
|
General and administrative |
|
|
22,866 |
|
|
|
22,036 |
|
|
|
3,949 |
|
|
|
69,321 |
|
|
|
10,569 |
|
Total operating expenses |
|
|
96,773 |
|
|
|
84,201 |
|
|
|
30,082 |
|
|
|
314,461 |
|
|
|
79,319 |
|
Operating loss |
|
|
(8,896 |
) |
|
|
(24,347 |
) |
|
|
(1,977 |
) |
|
|
(116,210 |
) |
|
|
(38,517 |
) |
Interest income |
|
|
10,912 |
|
|
|
10,264 |
|
|
|
1,724 |
|
|
|
23,730 |
|
|
|
4,875 |
|
Income (loss) before income taxes |
|
|
2,016 |
|
|
|
(14,083 |
) |
|
|
(253 |
) |
|
|
(92,480 |
) |
|
|
(33,642 |
) |
Income tax (benefit) provision |
|
|
9,609 |
|
|
|
(6,537 |
) |
|
|
2,871 |
|
|
|
15,654 |
|
|
|
6,940 |
|
Net loss |
|
$ |
(7,593 |
) |
|
$ |
(7,546 |
) |
|
$ |
(3,124 |
) |
|
$ |
(108,134 |
) |
|
$ |
(40,582 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net loss per share attributable to common stockholders: |
||||||||||||||||||||
Basic and diluted |
|
$ |
(0.05 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.89 |
) |
|
$ |
(1.11 |
) |
Weighted-average shares used in calculating net loss per share attributable to common stockholders: |
||||||||||||||||||||
Basic and diluted |
|
|
156,831 |
|
|
|
155,199 |
|
|
|
37,470 |
|
|
|
121,649 |
|
|
|
36,627 |
|
ASTERA LABS, INC. |
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In thousands) |
||||||||
|
|
Nine Months Ended |
||||||
|
|
September 30,
|
|
September 30,
|
||||
Cash flows from operating activities |
|
|
|
|
||||
Net loss |
|
$ |
(108,134 |
) |
|
$ |
(40,582 |
) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities |
|
|
|
|
||||
Stock-based compensation |
|
|
186,370 |
|
|
|
7,380 |
|
Inventory write-downs |
|
|
951 |
|
|
|
10,172 |
|
Depreciation |
|
|
2,180 |
|
|
|
1,241 |
|
Non-cash operating lease expense |
|
|
1,687 |
|
|
|
886 |
|
Warrants contra revenue |
|
|
946 |
|
|
|
438 |
|
Accretion of discounts on marketable securities |
|
|
(4,868 |
) |
|
|
(1,039 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
||||
Accounts receivable, net |
|
|
(17,054 |
) |
|
|
(6,494 |
) |
Inventory |
|
|
(1,271 |
) |
|
|
597 |
|
Prepaid expenses and other assets |
|
|
(4,998 |
) |
|
|
(220 |
) |
Accounts payable |
|
|
11,723 |
|
|
|
(663 |
) |
Accrued expenses and other liabilities |
|
|
31,094 |
|
|
|
2,184 |
|
Operating lease liability |
|
|
(1,653 |
) |
|
|
(1,015 |
) |
Net cash provided by (used in) operating activities |
|
|
96,973 |
|
|
|
(27,115 |
) |
|
|
|
|
|
||||
Cash flows from investing activities |
|
|
|
|
||||
Purchases of property and equipment |
|
|
(18,797 |
) |
|
|
(1,750 |
) |
Purchases of marketable securities |
|
|
(724,921 |
) |
|
|
(102,836 |
) |
Maturities of marketable securities |
|
|
36,579 |
|
|
|
29,000 |
|
Sales of marketable securities |
|
|
40,998 |
|
|
|
63,778 |
|
Net cash used in investing activities |
|
|
(666,141 |
) |
|
|
(11,808 |
) |
|
|
|
|
|
||||
Cash flows from financing activities |
|
|
|
|
||||
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions |
|
|
672,198 |
|
|
|
— |
|
Payment of deferred offering costs |
|
|
(4,801 |
) |
|
|
(105 |
) |
Tax withholding related to net share settlements of restricted stock units |
|
|
(20,111 |
) |
|
|
— |
|
Proceeds from exercises of stock options, net of repurchases |
|
|
2,901 |
|
|
|
662 |
|
Net cash provided by financing activities |
|
|
650,187 |
|
|
|
557 |
|
Net increase (decrease) in cash and cash equivalents |
|
|
81,019 |
|
|
|
(38,366 |
) |
Cash and cash equivalents |
|
|
|
|
||||
Beginning of the period |
|
|
45,098 |
|
|
|
76,088 |
|
End of the period |
|
$ |
126,117 |
|
|
$ |
37,722 |
|
ASTERA LABS, INC. |
||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited) (In thousands, except percentages and per share amounts) |
||||||||||||||||||||
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
September 30,
|
|
June 30,
|
|
September 30,
|
|
September 30,
|
|
September 30,
|
||||||||||
GAAP gross profit |
|
$ |
87,877 |
|
|
$ |
59,854 |
|
|
$ |
28,105 |
|
|
$ |
198,251 |
|
|
$ |
40,802 |
|
Stock-based compensation expense upon IPO (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
516 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
102 |
|
|
|
84 |
|
|
|
9 |
|
|
|
198 |
|
|
|
16 |
|
Non-GAAP gross profit |
|
$ |
87,979 |
|
|
$ |
59,938 |
|
|
$ |
28,114 |
|
|
$ |
198,965 |
|
|
$ |
40,818 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP gross margin |
|
|
77.7 |
% |
|
|
77.9 |
% |
|
|
76.1 |
% |
|
|
77.7 |
% |
|
|
62.5 |
% |
Stock-based compensation expense upon IPO (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.2 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
0.1 |
|
|
|
0.1 |
|
|
|
— |
|
|
|
0.1 |
|
|
|
— |
|
Non-GAAP gross margin |
|
|
77.8 |
% |
|
|
78.0 |
% |
|
|
76.1 |
% |
|
|
78.0 |
% |
|
|
62.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP operating loss |
|
$ |
(8,896 |
) |
|
$ |
(24,347 |
) |
|
$ |
(1,977 |
) |
|
$ |
(116,210 |
) |
|
$ |
(38,517 |
) |
Stock-based compensation expense upon IPO (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
88,873 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
45,535 |
|
|
|
43,067 |
|
|
|
2,711 |
|
|
|
97,497 |
|
|
|
7,380 |
|
Employer payroll tax related to stock-based compensation from IPO (2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,072 |
|
|
|
— |
|
Non-GAAP operating income (loss) |
|
$ |
36,639 |
|
|
$ |
18,720 |
|
|
$ |
734 |
|
|
$ |
71,232 |
|
|
$ |
(31,137 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP operating margin |
|
|
(7.9 |
)% |
|
|
(31.6 |
)% |
|
|
(5.3 |
)% |
|
|
(45.5 |
)% |
|
|
(59.0 |
)% |
Stock-based compensation expense upon IPO (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
34.8 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
40.3 |
|
|
|
56.0 |
|
|
|
7.3 |
|
|
|
38.2 |
|
|
|
11.3 |
|
Employer payroll tax related to stock-based compensation from IPO (2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.4 |
|
|
|
— |
|
Non-GAAP operating margin |
|
|
32.4 |
% |
|
|
24.4 |
% |
|
|
2.0 |
% |
|
|
27.9 |
% |
|
|
(47.7 |
)% |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
GAAP net loss |
|
$ |
(7,593 |
) |
|
$ |
(7,546 |
) |
|
$ |
(3,124 |
) |
|
$ |
(108,134 |
) |
|
$ |
(40,582 |
) |
Stock-based compensation expense upon IPO (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
88,873 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
45,535 |
|
|
|
43,067 |
|
|
|
2,711 |
|
|
|
97,497 |
|
|
|
7,380 |
|
Employer payroll tax related to stock-based compensation from IPO (2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,072 |
|
|
|
— |
|
Income tax effect (3) |
|
|
2,340 |
|
|
|
(13,296 |
) |
|
|
— |
|
|
|
(2,471 |
) |
|
|
— |
|
Non-GAAP net income (loss) |
|
$ |
40,282 |
|
|
$ |
22,225 |
|
|
$ |
(413 |
) |
|
$ |
76,837 |
|
|
$ |
(33,202 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net (loss) income per share attributable to common stockholders: |
||||||||||||||||||||
GAAP - basic and diluted |
|
$ |
(0.05 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.89 |
) |
|
$ |
(1.11 |
) |
Non-GAAP pro forma - diluted |
|
$ |
0.23 |
|
|
$ |
0.13 |
|
|
$ |
— |
|
|
$ |
0.46 |
|
|
$ |
(0.26 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Weighted average shares used to compute net (loss) income per share attributable to common stockholders: |
||||||||||||||||||||
GAAP - basic and diluted |
|
|
156,831 |
|
|
|
155,199 |
|
|
|
37,470 |
|
|
|
121,649 |
|
|
|
36,627 |
|
Non-GAAP pro forma - diluted (4) |
|
|
173,832 |
|
|
|
175,279 |
|
|
|
128,361 |
|
|
|
165,463 |
|
|
|
127,518 |
|
____________________ |
(1) Stock-based compensation expense recognized in connection with the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO. |
(2) Employer payroll taxes related to the time-based vesting and settlement of RSUs, that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO. |
(3) The income tax effect represents the impact of the non-GAAP adjustments on an after-tax basis and one-off discrete tax adjustments that are unrelated to our core operating performance in connection with the presentation of non-GAAP net income (loss) and non-GAAP pro-forma net income (loss) per diluted share. For the three months ended September 30, 2024 and June 30, 2024, the non-GAAP tax rates were approximately of |
(4) We present the non-GAAP pro-forma weighted average shares to provide meaningful supplemental information of comparable shares for each periods presented. The non-GAAP pro forma weighted average shares is calculated as follows: |
|
|
Three Months Ended |
|
Nine Months Ended |
||||||
|
|
September 30,
|
|
June 30,
|
|
September 30,
|
|
September 30,
|
|
September 30,
|
Shares used to compute GAAP net loss per share attributable to common stockholders - diluted |
|
156,831 |
|
155,199 |
|
37,470 |
|
121,649 |
|
36,627 |
Weighted average effect of the assumed conversion of redeemable convertible preferred stock from the beginning of the periods |
|
— |
|
— |
|
90,891 |
|
25,809 |
|
90,891 |
Effect of dilutive equivalent shares |
|
17,001 |
|
20,080 |
|
— |
|
18,005 |
|
— |
Shares used to compute non-GAAP pro forma net income (loss) per share- diluted |
|
173,832 |
|
175,279 |
|
128,361 |
|
165,463 |
|
127,518 |
ASTERA LABS, INC. |
|||||||||||||||
SUPPLEMENTAL FINANCIAL INFORMATION STOCK-BASED COMPENSATION EXPENSE (Unaudited) (In thousands) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
September 30,
|
|
June 30,
|
|
September 30,
|
|
September 30,
|
|
September 30,
|
||||||
Cost of revenue |
$ |
102 |
|
$ |
84 |
|
$ |
9 |
|
$ |
714 |
|
$ |
16 |
|
Research and development |
|
14,641 |
|
|
12,971 |
|
|
1,706 |
|
|
57,619 |
|
|
5,057 |
|
Sales and marketing |
|
16,200 |
|
|
15,758 |
|
|
691 |
|
|
81,216 |
|
|
1,386 |
|
General and administrative |
|
14,592 |
|
|
14,254 |
|
|
305 |
|
|
46,821 |
|
|
921 |
|
Total stock-based compensation expense (1) |
$ |
45,535 |
|
$ |
43,067 |
|
$ |
2,711 |
|
$ |
186,370 |
|
$ |
7,380 |
____________________ |
(1) Stock-based compensation expense recognized during the nine months ended September 30, 2024 included |
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104192654/en/
IR CONTACT: Leslie Green
leslie.green@asteralabs.com
Source: Astera Labs, Inc.
FAQ
What was Astera Labs (ALAB) revenue growth in Q3 2024?
What is Astera Labs (ALAB) Q4 2024 revenue guidance?
What was Astera Labs (ALAB) Q3 2024 non-GAAP earnings per share?